 JoAnn Zell
Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatology | 8 | 2026 | 136 | 2.420 |
Why?
| | Reproductive Health | 2 | 2026 | 94 | 1.660 |
Why?
| | Rheumatic Diseases | 3 | 2026 | 101 | 1.170 |
Why?
| | Rheumatologists | 2 | 2025 | 15 | 0.940 |
Why?
| | Reproductive Medicine | 1 | 2025 | 19 | 0.860 |
Why?
| | Lupus Erythematosus, Systemic | 5 | 2023 | 240 | 0.820 |
Why?
| | Counseling | 1 | 2026 | 403 | 0.730 |
Why?
| | Arthritis, Rheumatoid | 5 | 2024 | 1184 | 0.430 |
Why?
| | Pregnancy Complications | 2 | 2024 | 605 | 0.420 |
Why?
| | Quality Indicators, Health Care | 2 | 2023 | 340 | 0.380 |
Why?
| | Health Status Indicators | 2 | 2020 | 166 | 0.290 |
Why?
| | Pregnancy | 6 | 2026 | 7217 | 0.280 |
Why?
| | Autoantibodies | 1 | 2014 | 1498 | 0.250 |
Why?
| | Clinical Competence | 2 | 2025 | 1261 | 0.230 |
Why?
| | Practice Guidelines as Topic | 3 | 2025 | 1581 | 0.220 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2025 | 40 | 0.220 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.210 |
Why?
| | Cognition Disorders | 2 | 2022 | 547 | 0.210 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 83 | 0.200 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2024 | 124 | 0.200 |
Why?
| | Delphi Technique | 2 | 2024 | 347 | 0.200 |
Why?
| | Infertility, Female | 1 | 2024 | 124 | 0.200 |
Why?
| | Fertility | 1 | 2024 | 173 | 0.190 |
Why?
| | Self Efficacy | 1 | 2025 | 417 | 0.170 |
Why?
| | Autoimmune Diseases | 1 | 2025 | 466 | 0.160 |
Why?
| | Young Adult | 7 | 2026 | 14240 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 502 | 0.150 |
Why?
| | Culturally Competent Care | 1 | 2020 | 66 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 389 | 0.140 |
Why?
| | Female | 12 | 2026 | 79080 | 0.130 |
Why?
| | Motor Activity | 2 | 2019 | 701 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2026 | 1403 | 0.120 |
Why?
| | Middle Aged | 8 | 2026 | 36359 | 0.120 |
Why?
| | Qualitative Research | 1 | 2024 | 1720 | 0.120 |
Why?
| | Humans | 17 | 2026 | 145625 | 0.110 |
Why?
| | United States | 5 | 2025 | 16041 | 0.110 |
Why?
| | Societies, Medical | 1 | 2019 | 901 | 0.110 |
Why?
| | Teratogens | 1 | 2014 | 25 | 0.110 |
Why?
| | Adolescent | 4 | 2026 | 22451 | 0.110 |
Why?
| | Adult | 7 | 2026 | 40821 | 0.100 |
Why?
| | Urban Health Services | 1 | 2014 | 68 | 0.100 |
Why?
| | Internship and Residency | 1 | 2024 | 1269 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4329 | 0.090 |
Why?
| | Exercise Tolerance | 1 | 2014 | 288 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 179 | 0.080 |
Why?
| | Cognition | 2 | 2022 | 1286 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1531 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 727 | 0.080 |
Why?
| | Feasibility Studies | 1 | 2014 | 1125 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2014 | 769 | 0.070 |
Why?
| | Patient Participation | 1 | 2013 | 454 | 0.070 |
Why?
| | Quality of Health Care | 1 | 2012 | 692 | 0.060 |
Why?
| | Antirheumatic Agents | 2 | 2024 | 309 | 0.060 |
Why?
| | Mass Screening | 1 | 2014 | 1300 | 0.060 |
Why?
| | Utah | 1 | 2025 | 82 | 0.060 |
Why?
| | Healthcare Disparities | 1 | 2012 | 728 | 0.050 |
Why?
| | Physicians | 1 | 2013 | 954 | 0.050 |
Why?
| | Neuropsychological Tests | 2 | 2022 | 1136 | 0.050 |
Why?
| | Neuroglia | 1 | 2024 | 176 | 0.050 |
Why?
| | Workflow | 1 | 2024 | 181 | 0.050 |
Why?
| | Hydroxychloroquine | 1 | 2023 | 65 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2024 | 3633 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2023 | 110 | 0.050 |
Why?
| | Interviews as Topic | 1 | 2024 | 926 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2023 | 6449 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2024 | 6050 | 0.040 |
Why?
| | Students, Medical | 1 | 2024 | 380 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 536 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2020 | 297 | 0.030 |
Why?
| | Executive Function | 1 | 2022 | 461 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2025 | 1208 | 0.030 |
Why?
| | Curriculum | 1 | 2024 | 1074 | 0.030 |
Why?
| | Male | 5 | 2024 | 73014 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2014 | 17291 | 0.030 |
Why?
| | Registries | 1 | 2024 | 2382 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1663 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1444 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2014 | 543 | 0.020 |
Why?
| | Lyme Disease | 1 | 2013 | 58 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3396 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2013 | 108 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2910 | 0.020 |
Why?
| | Exercise Test | 1 | 2014 | 634 | 0.020 |
Why?
| | Health Surveys | 1 | 2013 | 511 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10840 | 0.020 |
Why?
| | Biological Products | 1 | 2013 | 257 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11744 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2012 | 3005 | 0.010 |
Why?
| | Child | 1 | 2024 | 22638 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5397 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 6045 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 5875 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3917 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 8087 | 0.010 |
Why?
| | Aged | 1 | 2012 | 26251 | 0.010 |
Why?
|
|
Zell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|